QR Code

Development and Clinical Evaluation of a Recombinant-Antigen-Based Cytomegalovirus Immunoglobulin M Automated Immunoassay Using the Abbott AxSYM Analyzer

A new microparticle enzyme immunoassay (MEIA), the Cytomegalovirus (CMV) Immunoglobulin M (IgM) test, was developed on the Abbott AxSYM analyzer. This test uses recombinant CMV antigens derived from portions of four structural and nonstructural proteins of CMV: pUL32 (pp150), pUL44 (pp52), pUL83 (pp...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Microbiol
Main Authors: Maine, G. T., Stricker, R., Schuler, M., Spesard, J., Brojanac, S., Iriarte, B., Herwig, K., Gramins, T., Combs, B., Wise, J., Simmons, H., Gram, T., Lonze, J., Ruzicki, D., Byrne, B., Clifton, J. D., Chovan, L. E., Wachta, D., Holas, C., Wang, D., Wilson, T., Tomazic-Allen, S., Clements, M. A., Wright, G. L., Lazzarotto, T., Ripalti, A., Landini, M. P.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology (ASM) 2000
Subjects:
Online Access:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC86469/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10747129/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.38.4.1476-1481.2000
Tags: Add Tag
No Tags, Be the first to tag this record!